B lymphocyte dysfunctions in HIV infection

被引:131
作者
De Milito, A [1 ]
机构
[1] Karolinska Inst, Ctr Microbiol & Tumor Biol, S-17177 Stockholm, Sweden
关键词
D O I
10.2174/1570162043485068
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
HIV establishes a chronic and latent infection that is not eliminated by the host immune defences. The virus induces extensive damage to the immune system, through virus-related and indirect pathogenic mechanisms. Both the cellular and the humoral arms of the immune system are unable to control the infection, which ultimately results in severe exhaustion of several lymphocyte functions and increased susceptibility to secondary and opportunistic infections. A striking pathological feature induced by the persistent viral replication is the aberrant activation of cells of the immune system. Among these cells, B lymphocytes are severely damaged and show signs of phenotypic and functional alterations. In parallel to the polyclonal B cell activation and hypergammaglobulinemia, B cells from patients show impaired reactivity to immunisation and in vitro activation signals. In addition, B lymphocytes from HIV-infected subjects are primed for apoptosis. The role of protective Immoral immunity in the control and clinical progression of HIV infection is still much debated and controversial. The aim of the present review is to discuss the mechanisms involved in the loss of B cell functions during HIV infection. In particular, we discuss the role that T and B cell immune activation plays for B cell polyclonal activation and loss of memory B lymphocytes. The current knowledge on B cell damage is also discussed in the context of anti-HIV therapeutic treatment.
引用
收藏
页码:11 / 21
页数:11
相关论文
共 191 条
  • [51] Abnormal expression of the B-cell homing chemokine receptor BLR1 during the progression of acquired immunodeficiency syndrome
    Forster, R
    Schweigard, G
    Johann, S
    Emrich, T
    Kremmer, E
    Nerl, C
    Lipp, M
    [J]. BLOOD, 1997, 90 (02) : 520 - 525
  • [52] GAINES H, 1987, LANCET, V1, P1249
  • [53] CD40 and B cell antigen receptor dual triggering of resting B lymphocytes turns on a partial germinal center phenotype
    Galibert, L
    Burdin, N
    deSaintVis, B
    Garrone, P
    VanKooten, C
    Banchereau, J
    Rousset, F
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (01) : 77 - 85
  • [54] Evidence for the HIV-1 phenotype switch as a causal factor in acquired immunodeficiency
    Glushakova, S
    Grivel, JC
    Fitzgerald, W
    Sylwester, A
    Zimmerberg, J
    Margolis, LB
    [J]. NATURE MEDICINE, 1998, 4 (03) : 346 - 349
  • [55] Apoptosis as an HIV strategy to escape immune attack
    Gougeon, ML
    [J]. NATURE REVIEWS IMMUNOLOGY, 2003, 3 (05) : 392 - 404
  • [56] Gougeon ML, 1997, J IMMUNOL, V158, P2964
  • [57] Programmed cell death as a mechanism of CD4 and CD8 T cell deletion in AIDS - Molecular control and effect of highly active anti-retroviral therapy
    Gougeon, ML
    Montagnier, L
    [J]. MECHANISMS OF CELL DEATH: THE SECOND ANNUAL CONFERENCE OF THE CELL DEATH SOCIETY, 1999, 887 : 199 - 212
  • [58] GRAS G, 1993, BLOOD, V81, P1808
  • [59] CD4+ T-cell depletion in HIV infection:: Are we closer to understanding the cause?
    Grossman, Z
    Meier-Schellersheim, M
    Sousa, AE
    Victorino, RMM
    Paul, WE
    [J]. NATURE MEDICINE, 2002, 8 (04) : 319 - 323
  • [60] Grulich AE, 1999, J ACQ IMMUN DEF SYND, V21, pS27